Page last updated: 2024-10-30

mepivacaine and Myofascial Pain Syndromes

mepivacaine has been researched along with Myofascial Pain Syndromes in 1 studies

Mepivacaine: A local anesthetic that is chemically related to BUPIVACAINE but pharmacologically related to LIDOCAINE. It is indicated for infiltration, nerve block, and epidural anesthesia. Mepivacaine is effective topically only in large doses and therefore should not be used by this route. (From AMA Drug Evaluations, 1994, p168)
mepivacaine : A piperidinecarboxamide in which N-methylpipecolic acid and 2,6-dimethylaniline have combined to form the amide bond. It is used as a local amide-type anaesthetic.

Myofascial Pain Syndromes: Muscular pain in numerous body regions that can be reproduced by pressure on TRIGGER POINTS, localized hardenings in skeletal muscle tissue. Pain is referred to a location distant from the trigger points. A prime example is the TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miyakoshi, N1
Shimada, Y1
Kasukawa, Y1
Saito, H1
Kodama, H1
Itoi, E1

Trials

1 trial available for mepivacaine and Myofascial Pain Syndromes

ArticleYear
Total dorsal ramus block for the treatment of chronic low back pain: a preliminary study.
    Joint bone spine, 2007, Volume: 74, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Local; Chronic Disease; Contrast Media; Female; Humans;

2007